ArticleScientific reports2023
Exploring the potential of a newly developed pectin-chitosan polyelectrolyte composite on the surface of commercially pure titanium for dental implants.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 15 citations in OpenAlex.
- Chitosan and Its Nanoparticles: A Multifaceted Approach to Antibacterial Applications.Nanomaterials (Basel, Switzerland) · 2025Review
- Cytotoxicity and antibacterial susceptibility assessment of a newly developed pectin-chitosan polyelectrolyte composite for dental implants.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pectin and chitosan are natural polysaccharides obtained from fruit peels and exoskeletons of crustaceans and insects. They are safe for usage in food products and are renewable and biocompatible. They have further applications as wound dressings, body fat reduction, tissue engineering, and auxiliary agents in drug delivery systems. The healing process is usually long and painful. Adding a new material such as a pectin-chitosan composite to the implant surface or body would create unique biological responses to accelerate healing and delivery of target-specific medication at the implant site. The present study utilized the electrospraying process to create pectin-chitosan polyelectrolyte composite (PCPC) coatings with various ratios of 1:1, 2:1, 1:2, 1:3, and 3:1 on commercially pure titanium substrates. By means of FESEM, AFM, wettability, cross-cut adhesion, and microhardness were assessed the PCPC coatings' physical and mechanical properties. Subsequently, the antibacterial properties of the coating composite were assessed. AFM analysis revealed higher surface roughness for group 5 and homogenous coating for group 1. Group 3 showed the lowest water contact angle of 66.7° and all PCPC coatings had significantly higher Vickers hardness values compared to the control uncoated CpTi samples. Groups 3 and 4 showed the best adhesion of the PCPC to the titanium substrates. Groups 3, 4, and 5 showed antibacterial properties with a high zone of inhibitions compared to the control. The PCPC coating's characteristics can be significantly impacted by using certain pectin-chitosan ratios. Groups 3 (1:2) and 4 (1:3) showed remarkable morphological and mechanical properties with better surface roughness, greater surface strength, improved hydrophilicity, improved adhesion to the substrate surface, and additionally demonstrated significant antibacterial properties. According to the accomplished in vitro study outcomes, these particular PCPC ratios can be considered as an efficient coating for titanium dental implants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.